The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Oct 21, 2026
Snapshot (as of Oct 21, 2026): AstraZeneca PLC (AZN) pays a $3.23 annual dividend, yielding 1.95% at $168.82/share. Next ex-dividend date 2026-08-07. 24 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.95%
Annual Dividend: $3.23 per share
Payout Ratio: 46.9%
Ex-Dividend Date: 2026-08-07
Dividend Frequency: annually
Sector: Healthcare
Years of Dividend History: 34
AstraZeneca PLC dividend investors get exposure to a global biopharmaceutical company behind oncology drugs like Tagrisso and Imfinzi, cardiovascular treatments like Farxiga, and respiratory medicines like Symbicort. The current yield stands at 2.01%, with trailing twelve-month payments of $3.23 per share paid annually. The next ex-dividend date is August 7, 2026. A beta of 0.212 points to low price volatility, which suits income investors who prioritize predictability over price swings.
AstraZeneca PLC pays out 46.9% of earnings as dividends, a payout ratio classified as moderate (40–60%). That level leaves meaningful earnings retained within the business, supporting the current payment across AZN's broad portfolio of prescription medicines spanning oncology, cardiovascular, renal, and rare disease therapies. AstraZeneca PLC dividend safety faces its most data-visible pressure from the slow pace of dividend growth, which at 1.1% per year leaves little buffer if earnings come under pressure from drug pricing or pipeline setbacks.
AstraZeneca PLC dividend history shows a CAGR of 1.1% per year from 2011 to 2025. Per-share payments moved from $2.70 to $3.1581 over that span (2026 data is partial and excluded from the CAGR calculation). Growth was flat for several years in the middle of the window, with the dividend holding at $2.80 from 2013 through 2018 before edging higher. The largest annual increase in the window was 6.3% in 2025, the strongest single-year move in the available data.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +2.9% | $2.90 (2022) | $3.16 (2025) |
| 5-Year | +2.5% | $2.80 (2020) | $3.16 (2025) |
| 10-Year | +1.2% | $2.80 (2015) | $3.16 (2025) |
AZN stock fits dividend investors who want low price volatility and a moderate, well-covered yield from a diversified pharmaceutical business. The yield of 2.01% sits in the moderate (2–4%) range and is nearly in line with the 5-year average of 2.05%, so there is no meaningful valuation gap to exploit on yield alone. Growth is slow at 1.1% per year, and that limits the income compounding story over time. What AZN offers in return is a 46.9% payout ratio that keeps the dividend covered, a 24-year streak of consecutive increases, and a beta of 0.212 that keeps portfolio volatility low.
| Payment Date | Amount per Share |
|---|---|
| 2026-08-07 | $1.0600 |
| 2026-02-20 | $2.1700 |
| 2025-08-08 | $1.0300 |
| 2025-02-21 | $2.1281 |
| 2024-08-09 | $1.0000 |
| 2024-02-22 | $1.9700 |
| 2023-08-10 | $0.9300 |
| 2023-02-23 | $1.9700 |
| 2022-08-11 | $0.9318 |
| 2022-02-24 | $1.9700 |
| Year | Total Dividends |
|---|---|
| 2026 | $3.2300 |
| 2025 | $3.1581 |
| 2024 | $2.9700 |
| 2023 | $2.9000 |
| 2022 | $2.9018 |
Project income from AZN with the AZN dividend calculator or track your full portfolio with the dividend tracker.